Methods and compositions for reducing parathyroid levels
US11672809B2 · kind B2 · utility
0Cited by
138References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 29, 2011 |
| Grant date | Jun 13, 2023 |
| Priority date | — |
| Expiry date | Mar 29, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P5/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods and compositions for reducing serum parathyroid levels in, for example, chronic kidney disease patients are disclosed. In these methods, an effective amount of a modified release formulation of 25-hydroxy vitamin D is orally administered to a patient suffering from secondary hyperparathyroidism to lower the patient's serum intact parathyroid hormone (iPTH) level, while avoiding a surge in serum total 25-hydroxy vitamin D.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.